Health and Medicine
Sep. 22, 2011—The discovery of new compounds that work in a fundamentally different way than those in existing schizophrenia medications may allow for more normal function of brain cells involved in schizophrenia.
Sep. 21, 2011—Resource for physicians and parents created to make routine medical procedures less stressful for children with autism.
Sep. 15, 2011—Researchers at Vanderbilt University Medical Center, in collaboration with Seaside Therapeutics in Cambridge, Mass., have achieved a milestone in the development of a potential new treatment for fragile X syndrome, the most common genetic cause of autism.
Sep. 15, 2011—A new study shows ophthalmologic antibiotics promote antimicrobial resistance, prompting a call from Vanderbilt Eye Institute physicians to be more judicial in administering the drugs.
Sep. 15, 2011—A new study indicates that patients with high-grade glioma brain tumors who have preexisting type 2 diabetes or obesity have poorer outcomes, and is the first to use the Vanderbilt Brain Tumor Center Clinical Database to report a novel clinical finding.
Sep. 2, 2011—There is a list, famous among astronomers, of 110 faint objects in the night sky, first cataloged by French astronomer Charles Messier in the 18th century. A “Messier marathon” is when astronomers begin at dusk and work until dawn, hoping to locate every single one, searching amid the field of stars for each elusive light...
Aug. 18, 2011—Researchers have discovered how key proteins are “turned on” and transmit signals inside the cell. The discovery could lead to new, more effective drugs.